Praxbind
NDC 0597-0197, idarucizumab, injection, from Boehringer Ingelheim Pharmaceuticals, Inc..
- Product NDC
- 0597-0197
- Status
- Listed
- Labeler
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761025
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0597-0197 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IDARUCIZUMAB50 mg/mL
Pharmacologic classes
Antibodies, Monoclonal, Humanized [CS]; Humanized Monoclonal Antibody Fragment [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0597-0197-05 | 00597019705 | 2 VIAL, SINGLE-DOSE in 1 CARTON (0597-0197-05) / 50 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c7400f8a-dcf4-a6df-6d07-983081b1bf34
Use it
Look up 0597-0197 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0597-0197 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0597-0197. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.